AC
AC is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
Clinical Trials (5)
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5